Peptide Vial Strengths Explained: 5mg vs 10mg vs 20mg vs 30mg
Published: 2026-08-03 · Last updated: 2026-08-03
Every research peptide comes in a range of vial strengths — 5 mg, 10 mg, 20 mg, sometimes 30 mg for popular sequences. The choice affects price per mg, working shelf life, and storage risk. This guide walks through the trade-offs in plain English, with no dosing talk, so you can pick a vial size that actually fits how you work rather than just picking the one that looks cheapest on paper.
What does vial strength actually mean?
Vial strength is the total mass of peptide in the vial, in milligrams, before you add any water. A 10 mg vial contains 10 mg of freeze-dried peptide powder sitting at the bottom. That is the whole spec. It does not tell you anything about concentration, because concentration is what you decide at reconstitution.
The physical vial is usually the same 3 mL glass container regardless of whether it holds 5 mg or 30 mg of peptide — the powder pucks are small either way, and vendors standardise the vial geometry. What changes is the density of the pellet at the bottom. A 30 mg vial has more visible material than a 5 mg vial, but it is still a small amount and easy to miss if you are not looking for it.
Because concentration is set at reconstitution (see the reconstitution guide for the math), a 30 mg vial with 3 mL of bacteriostatic water gives you the same 10 mg/mL working concentration as a 10 mg vial with 1 mL of water. The vial size does not force any particular concentration on you.
Why is bigger usually cheaper per mg?
The cost of producing a research peptide vial is largely fixed: the glass container, the rubber stopper, the aluminum crimp, the freeze-dry cycle, the batch testing, the packaging, the shipping-safe outer box. Doubling the mg inside adds only a little more raw peptide cost. So doubling the mg does not double the price.
In practice, this shows up as a diminishing-returns curve. Going from 5 mg to 10 mg often cuts your per-mg cost noticeably. Going from 10 mg to 20 mg cuts it further. Going from 20 mg to 30 mg cuts it a little more, but the curve is flattening out. By the time you are at the biggest size a vendor offers, most of the per-mg savings have already been captured.
The exact ratios depend on the vendor's pricing strategy and the peptide itself. Cheaper, easier-to-make peptides show smaller per-mg jumps between sizes because the raw material is already inexpensive. Expensive, hard-to-make peptides (GLP-1s, tesamorelin) show bigger per-mg jumps because raw material dominates the cost. Our peptides catalogue shows current per-vial prices side by side so the comparison is easy.
How does vial size affect storage and shelf life?
Once reconstituted, a vial is going into the fridge and starting a two-to-four-week clock before the peptide starts noticeably degrading. Bigger vials at the same concentration contain more solution, which takes longer to use up. If you reconstitute a 30 mg vial and only work through 10 mg of it in three weeks, the remaining 20 mg is going off in the fridge while you use it.
The workarounds are aliquoting (splitting the reconstituted stock into single-use frozen tubes) and reconstituting into a higher concentration so the working volume is smaller. Both work. Aliquoting is more disciplined but adds a step at the start. Higher concentration is simpler but means smaller unit draws on the syringe, which is fine if your syringe reads well at those numbers.
Lyophilised (unreconstituted) storage life is different — a dry vial in the freezer lasts a year or more regardless of size. See the storage guide for the fuller picture. The size-driven shelf life problem only kicks in once you crack the seal.
Which size makes sense for a first-time buyer?
For a peptide you have not used before, buy small. A 5 mg or 10 mg vial lets you get through the reconstitution process, verify the vendor's product is what they said it was (batch number matches the CoA, dissolves cleanly, no visible particulates), and confirm that this peptide is going to fit into your work. Committing to a 30 mg vial of something that turns out to be wrong for you is expensive.
For a peptide you have used many times and know you are going to keep using, buy at the larger sizes. The per-mg savings add up over a year, and you already know the vendor's product is good. Just make sure your working pace matches — buying a 30 mg vial of something you use once a month is not saving you anything if two-thirds of it goes off before you finish.
Half-kits and full-kits are pricing bundles vendors offer to sell multiple vials at once. They are usually the best per-mg deal available if you know you want the material. If you are still figuring out whether a peptide is right for your research, ignore the bundles and buy a single vial. Our first-time buyer checklist covers the broader decisions.
Are there peptides where size choice matters more?
Yes. GLP-1 peptides (semaglutide, tirzepatide, retatrutide) are expensive per mg, so the per-vial price gap between sizes is significant. The larger vials save real money. But they are also more sensitive to freeze-thaw and long fridge storage, so the aliquoting discipline matters more.
Copper peptides like GHK-Cu are usually sold in smaller vials because they are used in smaller quantities per session and because the copper complex is a bit fussier about long storage in solution. Buying a 30 mg vial of GHK-Cu does not really exist for most vendors.
Robust peptides like BPC-157, TB-500, and CJC-1295 come in many sizes because there is demand at every tier. These are the peptides where you have the most choice, and where larger vials are the safest cost-optimisation play because the compound itself is stable and forgiving. See the healing peptide comparison guide for more on that class.
Questions Canadian buyers ask
Is a bigger vial always cheaper per mg?
Almost always. Vendors have a fixed cost per vial (glass, stopper, freeze-dry cycle, testing, packaging) that gets amortised over more mg as the vial gets bigger. A 20 mg vial is rarely twice the price of a 10 mg vial. That said, the per-mg savings shrink at the top end — the jump from 5 to 10 mg is bigger than the jump from 20 to 30 mg.
What is the point of a smaller vial then?
Two reasons. First, freshness: a smaller vial gets finished faster, so you rotate through fresh reconstituted material more often. Second, testing new peptides: if you are not sure a compound is going to be part of your research going forward, buying a 5 mg vial to try it is cheaper than committing to a 30 mg.
Does bigger vial mean higher concentration?
No. Concentration is entirely under your control at reconstitution. A 30 mg vial with 3 mL of water is the same 10 mg/mL as a 10 mg vial with 1 mL. The vial mg is total capacity; concentration is a math choice.
Why do some products only come in one size?
Manufacturer choice, usually driven by demand or by the peptide itself. Rare or expensive-to-make peptides often only come in smaller sizes. Very popular research peptides (BPC-157, TB-500) come in many sizes because there is enough demand at each tier to justify the SKU.
Should I buy multiple small vials or one big one?
Multiple smaller vials for storage safety, one big vial for cost. If you break a 30 mg vial or one goes off in the fridge, you lose 30 mg. If you break a 10 mg vial with two more still frozen, you lose 10. The trade-off is straight cost versus insurance.